Neuronetics (STIM) Depreciation & Amortization (CF) (2017 - 2026)
Neuronetics (STIM) posted quarterly Depreciation & Amortization (CF) of $745000.0 for Q1 2026, down 18.22% year-over-year from $911000.0 in Q1 2025, and down 2.87% quarter-over-quarter from $767000.0 in Q4 2025.
Neuronetics (STIM) Depreciation & Amortization (CF) (2017 - 2026) Analysis & Trends
Neuronetics (STIM) has reported Depreciation & Amortization (CF) for 10 consecutive years, with $745000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Depreciation & Amortization (CF) fell 18.22% year-over-year to $745000.0; the TTM figure through Mar 2026 stood at $3.3 million (up 36.1% YoY), while the FY2025 annual figure was $3.5 million, up 67.15% from the prior year.
- Depreciation & Amortization (CF) eased to $745000.0 in Q1 2026 per STIM's latest filing, from $767000.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $911000.0 in Q1 2025 and bottomed at $319000.0 in Q1 2022.
- Historically, Depreciation & Amortization (CF) has averaged $584529.4 across 5 years, with a median of $516000.0 in 2023.
- Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) soared 106.85% — and 2026, when it fell 18.22%.
- Neuronetics' Depreciation & Amortization (CF) stood at $604000.0 in 2022, then declined by 16.72% to $503000.0 in 2023, then decreased by 11.33% to $446000.0 in 2024, then jumped by 71.97% to $767000.0 in 2025, then slipped by 2.87% to $745000.0 in 2026.
- Business Quant data shows STIM's Depreciation & Amortization (CF) at $745000.0 in Q1 2026, $767000.0 in Q4 2025, and $886000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 355.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 42.70 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 68.20 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 750.89 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 123.80 Mn |
| 10 | Neuronetics | 225.97 Mn | 206.54 Mn | 21.22 Mn | 729,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 729,000.00 |
| Jun 30, 2026 | 729,000.00 |
| Mar 31, 2026 | 745,000.00 |
| Mar 31, 2026 | 745,000.00 |
| Dec 31, 2025 | 767,000.00 |
| Dec 31, 2025 | 767,000.00 |
| Sep 30, 2025 | 886,000.00 |
| Sep 30, 2025 | 886,000.00 |
| Jun 30, 2025 | 901,000.00 |
| Jun 30, 2025 | 901,000.00 |
| Mar 31, 2025 | 911,000.00 |
| Mar 31, 2025 | 911,000.00 |
| Dec 31, 2024 | 446,000.00 |
| Dec 31, 2024 | 446,000.00 |
| Sep 30, 2024 | 512,000.00 |
| Sep 30, 2024 | 512,000.00 |
| Jun 30, 2024 | 555,000.00 |
| Jun 30, 2024 | 555,000.00 |
| Mar 31, 2024 | 560,000.00 |
| Mar 31, 2024 | 560,000.00 |